BioInvent International AB(SE:BINV)
kr 2.92-0.00 (-0.17%)
SE:BINV
BioInvent International AB earnings date
kr 2.92
At close:-0.00 (-0.17%)
Want to see SE:BINV full AI Analyst Report?
BioInvent International AB (BINV) Q3 2022 Earnings Report
2 Followers
SE:BINV Q3 2022 EPS Results
- Actual EPS
- -SEK 1.00
- Consensus EPS
- -SEK 11.50
- Beat/Miss
- Beat by +SEK 10.50
- One Year Ago EPS
- -SEK 1.07
SE:BINV Q3 2022 Revenue Results
- Actual Revenue
- SEK 17.92M
- Expected Revenue
- SEK 80.37M
- Beat/Miss
- Missed by -SEK 62.45M
- YoY Revenue Growth
- +498.73%
Earnings Announcement Details
- Quarter
- Q3 2022
- Date
- 10/27/2022
- Time
- Before Open
- Conference Call
- Thursday, October 27, 2022
SE:BINV Upcoming Earnings
BioInvent International AB's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q3 2022 Earnings Call Audio
SE:BINV Q3 2022 Earnings Call
0:00 / 0:00
Q3 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
SE:BINV Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -1.07- | -1.91 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -1.98-1.81 | -1.96 | 7.99% (+0.16) | |
| Aug 27, 2026 | 2026 (Q2) | -1.90-1.87 | 0.59 | -416.61% (-2.46) | |
| Apr 29, 2026 | 2026 (Q1) | -1.90-1.90 | -1.77 | -7.39% (-0.13) | |
| Feb 26, 2026 | 2025 (Q4) | ―-1.91 | -1.78 | -7.55% (-0.13) | |
| Oct 29, 2025 | 2025 (Q3) | ―-1.96 | -1.48 | -32.88% (-0.49) | |
| Aug 26, 2025 | 2025 (Q2) | ―0.59 | -2.09 | 128.27% (+2.68) | |
| Apr 29, 2025 | 2025 (Q1) | ―-1.77 | -1.18 | -49.66% (-0.59) | |
| Feb 27, 2025 | 2024 (Q4) | ―-1.78 | -1.48 | -20.33% (-0.30) | |
| Oct 31, 2024 | 2024 (Q3) | ―-1.48 | -1.08 | -36.85% (-0.40) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
